SEC Form 4 · accession 0001209191-18-051667
Xylem Inc. · XYL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Colin R Sabol
Officer — Senior Vice President
Period of report
Sep 17, 2018
Accepted (ET)
Sep 19, 2018 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001524472
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 17, 2018 | M | 7,017 | $38.76 | A | 41,988 | D | |
| Common StockF1,F2 | Sep 17, 2018 | S | 7,017 | $81.37 | D | 34,971 | D | |
| Common Stock | Sep 17, 2018 | M | 4,000 | $35.96 | A | 38,971 | D | |
| Common StockF1,F3 | Sep 17, 2018 | S | 4,000 | $81.37 | D | 34,971 | D | |
| Common StockF4,F5 | Sep 17, 2018 | S | 3,644 | $81.37 | D | 31,327 | D | |
| Common StockF4,F6 | Sep 17, 2018 | S | 2,500 | $81.37 | D | 28,827 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F7 | $38.76 | Sep 17, 2018 | M | 7,017 | D | — | Feb 25, 2024 | Common Stock | 7,017 | 0 | D |
| Employee Stock Option (Right to Buy)F7 | $35.96 | Sep 17, 2018 | M | 4,000 | D | — | Feb 25, 2025 | Common Stock | 4,000 | 15,930 | D |
Explanation of responses
- F1The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on August 17, 2018.
- F2This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $80.85 to $81.63 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- F3This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $80.87 to $81.64 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- F4The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on August 17, 2018
- F5This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $80.84 to $81.60 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
- F6This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $80.91 to $81.64 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
- F7These options are fully vested and exercisable.